序号 |
作者 |
题目 |
影响 因子 |
刊名 |
年卷页码 |
1 |
Huang SN, Duan SF, Wang J, Bao SJ, Qiu XJ, Li CM, Liu Y, Yan LJ, Zhang ZZ, Hu YR |
Folic-Acid-Mediated Functionalized Gold Nanocages for Targeted Delivery of Anti-miR-181b in Combination of Gene Therapy and Photothermal Therapy against Hepatocellular Carcinoma |
11.382 |
Adv Funct Mater |
2016; 26: 2532-2544 |
2 |
Shi JJ, Wang BH, Wang L, Lu TT, Fu Y, Zhang HL, Zhang ZZ |
Fullerene (C60)-based tumor-targeting nanoparticles with “off-on” state for enhanced treatment of cancer |
7.44 |
Journal of Controlled Release |
2016;235:245-258 |
3 |
Shi JJ, Chen ZY, Wang L, Wang BH, Xu LH, Hou L, Zhang ZZ |
A tumor-specific cleavable nanosystem of PEG-modified C60@Au hybrid aggregates for radio frequency-controlled release, hyperthermia, photodynamic therapy and X-ray imaging |
6.03 |
Acta Biomaterialia |
2016;29:282-297 |
4 |
Feng QH, Zhang YY, Zhang WX, Shan XN, Yuan YJ, Zhang HL, Hou L, Zhang ZZ |
Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography |
6.008 |
Acta Biomaterialia |
2016;38:129-142 |
5 |
Du B, Han SP, Zhao FF, Lim KH, Xi HW, Su XJ, Yao HC |
A smart upconversion-based light-triggered polymer for synergetic chemo-photodynamic therapy and dual-modal MR/UCL imaging |
5.671 |
Nanomed: Nanotechnol Biol Med |
2016; 2071-2080 |
6 |
Du B, Cao XH, Zhao FF, Su XJ, Wang YH, Yan XS, Jia SN, |
Multimodal imaging-guided, dual-targetedphotothermal therapy for cancer |
4.872 |
J Mater Chem B |
2016; 4:2038-2050 |
7 |
Wang L, Meng DH, Hao YW, Hu YJ, Niu MY, Zheng CX, Yin YY, Li D, Zhang PP, Chang JB, Zhang ZZ, Zhang Y |
A gold nanostar based multi-functional tumor-targeting nanoplatform for tumor theranostic applications |
4.872 |
Journal of Material Chemistry B |
2016; 4: 5895-5906 |
8 |
Li HX, Hao YW, Wang N, Jia SS,Wang YL, Yang LJ, Zhang Y, Zhang ZZ |
DOTAP functionalizing single-walled carbon nanotubes as non-viral vectors for efficient intracellular siRNA delivery |
4.843 |
Drug Delivery |
2016; 220: 840-848. |
9 |
Ren XL, Liu L, Zhou YX, Zhu Y, Zhang H, Zhang ZZ, Li HX |
Nanoparticle siRNA against BMI-1 with a Polyethylenimine-Laminarin Conjugate for Gene Therapy in Human Breast Cancer |
4.513 |
Bioconjugate Chem. |
2016; 27:66-73 |
10 |
Hou L, Yang XM, Ren JX, Wang YC, Zhang HJ, Feng QH, Shi YY, Shan XN, Yuan YJ, Zhang ZZ |
A novel redox-sensitive system based on single-walled carbon nanotubes for chemo-photothermal therapy and magnetic resonance imaging. |
4.383 |
Int J Nanomedicine |
2016; 11: 607-624 |
11 |
Yao HC, Su L, Zeng M, Cao L, Zhao WW, Chen CQ, Du B. |
Construction of magnetic-carbon-quantum-dots-probe-labeled apoferritin nanocages for bioimaging and targeted therapy. |
4.383 |
Int J Nanomedicine |
2016;11: 4423-4438 |
12 |
Hao HW, Wang L, Zhang BX, Li D, Meng DH, Shi JJ, Zhang HL, Zhang ZZ , Zhang Y |
Manganese dioxide nanosheets-based redox/pH-responsive drug delivery system for cancer theranostic application |
4.383 |
International Journal of Nanomedicine |
2016; 11: 1759-1778 |
13 |
Zhang N, Li SS, Hua HY, Liu D, Song LL, Sun PC, Huang WW, Tang YF, Zhao YX |
Low density lipoprotein receptor targeted doxorubicin/DNA-Gold Nanorods as a chemo- and thermo-dual therapy for prostate cancer. |
3.994 |
Int J Pharm |
2016, 513:376-386. |
14 |
Shi JJ, Pan JJ, Wang BH, Luo Zhao, Hou L, Zhang ZZ |
Efficient remote NIR-controlled drug delivery into tumor cells by nanoplatform modified with tumoral-acid-cleavable PEG |
3.95 |
Journal of Biomedical Nanotechnology |
2016;12:1-15 |
15 |
Hou L, Feng QH, Wang YT, Ren JX, Yang XM, Shi YY, Shan XN, Yuan YJ, Wang YC, Zhang ZZ |
Multifunctional hyaluronic acid modified graphene oxide loaded with mitoxantrone for overcoming drug resistance in cancer |
3.573 |
Nanotechnology |
2016, 27:015701. |
16 |
Hou L, Shi YY, JiangGX, Liu W, Han HL, Feng QH, Ren JX, Yuan YJ, Wang YC,Shi JJ, Zhang ZZ |
Smart nanocomposite hydrogels based onazo crosslinked graphene oxide for oralcolon-specific drug delivery |
3.573 |
Nanotechnology |
2016;27:315105 |
17 |
Hao YW, Wang L, Zhang BX, Zhao HJ, Niu MY, Hu YJ, Zheng GX, Zhang HL, Chang JB , Zhang ZZ, Zhang Y |
Multifunctional nanosheets based on folic acid modified manganese oxide for tumor targeting theranostic application |
3.573 |
Nanotechnology |
2016; 27: 025101 |
18 |
Zhou J, Chen SS, Sun C, Du QZ, Luo P, Du B, Yao HC |
A “submunition” dual-drug system based on smart hollow NaYF4/apoferritin nanocage for upconversion imaging |
3.289 |
RSC advances |
2016, 6: 33443 –3 454 |
19 |
Shi JJ, Wang BH, Chen ZY , Liu W, Pan JJ, Hou L , Zhang ZZ |
A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy |
3.26 |
Pharm Res |
2016;33:1472-1485 |
20 |
Liu W, Pan H, Zhang CY, Zhao LL, Zhao RX, Zhu YT, Pan WS |
Developments in Methods for Measuring the Intestinal Absorption of Nanoparticle-Bound Drugs |
3.257 |
International Journal of Molecular Sciences |
2016;17:1171-1191 |
21 |
Niu L, Ding L, Lu C, Zuo F, Yao K, Xu S, Li W, Yang D, Xu X |
Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations. |
2.99 |
J Ethnopharmacol |
2016 15;191:350-9. |
22 |
Huang WW, Zhang N, Hua HY, Liu TB, Tang YF, Fu LL, Yang YN, Ma XJ, Zhao YX |
pharmacokinetics and pharmacodynamics of ophthalmic thermosensitive in situ hydrogel of betaxolol hydrochloride |
2.326 |
Biomed Pharmacother |
2016, 83:107-113 |
23 |
Zhang N, Miao JH, Sun PC, Liang Q, Hua HY, Xu YS, Zhao YX |
Pharmacokinetics, tissue distribution and anti-tumor effect of low density lipoprotein peptide conjugated submicron emulsions. |
2.326 |
Biomed Pharmacother. |
2016;82:614-619 |
24 |
Zhou J, Sun F, Du QZ, Zhao SZ, Pei WJ |
Enantioseparation of Timolol on a Novel β-Cyclodextrin Derivative Chiral Stationary Phase in HPLC |
1.320 |
Journal of Chromatographic Science |
2016, 54 :43–47 |
25 |
Zhou J, Luo P, Chen SS, Meng LC, Sun C,Du QZ, Sun F |
Enantioseparation of Six Antihistamines withImmobilized Cellulose Chiral StationaryPhase by HPLC |
1.320 |
Journal of Chromatographic Science |
2016, 54:531–535 |
26 |
Piao JY, Yan SJ, Gao SL, Chen Y, Xu X. |
The Antitumor Effect of DYC-279 on Human Hepatocellular Carcinoma HepG2 Cells. |
1.2 |
Pharmacology. |
2016;97:177-83. |
27 |
Yao HC, Long XF, Cao L, Zeng M, Zhao WW, Du B, Zhou J |
|
|
RSC Advances |
2016, 6:2046-2069 |
28 |
赵瑞霞,王慧玲,赵丽玲,张彩云,章锦丽,刘伟 |
2005-2014年我国基本药物不良反应文献计量学分析 |
0.713 |
中国药房 |
2016;27:1156-1160 |
29 |
李银英,陈成群,张振中 |
2-甲氧基雌二醇联合冬凌草甲素对胃癌 SGC-7901 细胞增殖和凋亡的影响 |
|
郑州大学学报 |
2016.51:602-605 |
30 |
李桃英,张振中,李志业,张涛志,李占武,邢玲 |
一例老年医院获得性肺炎患者应用替考拉宁治疗的药学监护 |
|
临床合理用药 |
2016. 9:160-161 |
31 |
杨艳华,林素静,刘西京,杜斌 |
|
|
深圳职业技术学院学报 |
2016;1:45-49 |
32 |
宋丽莉,孙朋超,黄维维,梁倩,赵永星 |
替米考星水溶性粉在家兔体内的药动学研究 |
|
中国兽医杂质 |
2016, 52:105-108 |